Tom Sellig, Adare, discusses 3D-printed tablets, US reshoring investment, FDA timeline pressures, and workforce development strategies driving CDMO growth.
Tom Sellig
Advertisement
CEO, Adare Pharma Solutions
Articles by Tom Sellig
Tom Sellig, Adare Pharma Solutions, shares how the CDMO is positioning for growth amid US reshoring and oral dose innovation trends.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Updates Master Protocol: What Developers Need to Know
2
Pharma Fundamentals: Hold Times in Biopharmaceuticals
3
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
4
Merck KGaA Launches Saturnus Bio; Announces Awards
5